Catalogued
Eric C. Leas, PhD, MPH – Herbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego
This dataset contains de-identified survey data from a nationally sampled, probability-based online survey of U.S. adults conducted by Ipsos Public Affairs on behalf of the University of California San Diego in October–November 2023. Respondents were recruited from Ipsos KnowledgePanel, and the survey was administered in English and Spanish.
The final main survey file includes 2,880 screening respondents, including 1,525 qualified respondents, and 314 variables. Survey measures cover CBD use prevalence and frequency, product type, dose, mode of use, purchase source, purposes for use, health conditions, clinician recommendation, medication substitution and adjunct use, self-reported adverse events, other substance use, awareness and use of derived cannabinoid products including delta-8-THC, CBN, CBG, and HHC, microdosing of cannabis and selected psychedelic substances, self-rated physical and mental health, quality of life, demographics, geographic profile variables, and survey weights.
The dataset is intended to support research on cannabinoid product use, health behaviors, policy environments, and public health implications among U.S. adults.
Date range, conditions covered and surveys completed are not published for a single study: the public aggregate carries a participant count only. Repository-wide breakdowns are on the statistics page.
Last refreshed 43 minutes ago.
Aggregate counts only. Groups smaller than 10 are shown as a range.
Administered jointly by Realm of Caring and Johns Hopkins University under NIH award 1UM1DA059000 (NIDA).
